Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Kobo Biotech Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹7.82 |
|---|---|
| Day's Range | ₹7.82 - ₹7.82 |
| Open | ₹7.82 |
| 52 Week Range | ₹01.99 - ₹07.67 |
| Volume | 59,488 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 4.65 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -14.61 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | -33.48 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -4.10 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 0.0 | 0.0 |
| Expenses | 0.0 | 0.0 |
| PBT | -12.26 | -55.54 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -12.26 | -55.53 |
About Kobo Biotech Ltd.
| Founded | 1993 |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,49,299.47 | 1,864.60 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,74,207.12 | 6,602.05 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,56,449.79 | 4,622.60 | 3,287.30 - 3,287.30 |
| Apollo Hospitals Enterprise Ltd. | 1,24,925.14 | 8,688.35 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,18,361.46 | 1,468.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,13,252.99 | 1,356.85 | 1,148.40 - 1,148.40 |
| Max Healthcare Institute Ltd. | 1,11,996.03 | 1,129.30 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,11,885.02 | 1,112.20 | 835.50 - 835.50 |
| Lupin Ltd. | 1,10,657.13 | 2,420.15 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,02,641.89 | 2,550.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Bharat Parenterals informs about disclosure
Anlon Healthcare informs about trading window closure
Earkart informs about press release
Shilpa Medicare informs about disclosure
Pursuant to Regulation 30 read with other applicable provisions of the SEBI Listing Regulations, Shilpa Medicare has informed that Shilpa Biologicals (SBPL), a wholly owned subsidiary of the Company, has entered into Co-development and supply agreement with Orion Corporation (‘Orion’) a globally recognized pharmaceutical company headquartered in Finland. Details with respect to the above-mentioned event as required under Regulation 30 of Schedule Ill of the SEBI Listing Regulations and SEBI Circular dated 30th January 2026 are provided in Annexure I to this letter. A press release to be issued in relation to the above matter is enclosed.
The above information is a part of company’s filings submitted to BSE.
Bliss GVS Pharma informs about closure of trading window
Bliss GVS Pharma has informed that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of the Company will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Wednesday, July 01, 2026 till completion of 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter ended on June 30, 2026 generally made available to the public. The Board meeting for the declaration of Unaudited Financial Results for the quarter ended June 30, 2026, shall be intimated later. Accordingly, Insiders, Designated Persons, and their immediate relatives are advised not to trade (buy or sell or pledge, etc.) in the securities/shares of the Company during the aforesaid period of closure of the Trading Window.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Kobo Biotech Ltd. is ₹7.82 as of 2026-06-30.
The market capitalisation of Kobo Biotech Ltd. is ₹18.27 as of 2026-06-29.
The 1-year return of Kobo Biotech Ltd. is 5.47% as of 2025-06-27.
The P/E ratio of Kobo Biotech Ltd. is 0.00 as of 2026-06-30.
The 52-week high and low of Kobo Biotech Ltd. are ₹7.67 and ₹1.99, respectively, as of 2026-06-30.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
